Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP   4:00:00 PM EDT
0.58
+0.01 (+1.51%)
: $0.58 0.00 (0.14%)
Mergers / Acquisitions

Tonix Pharmaceuticals To Acquire Preclinical Infectious Disease Portfolio From Healion Bio

Published: 02/02/2023 13:28 GMT
Tonix Pharmaceuticals Holding Corp (TNXP) - Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio From Healion Bio, Inc.tonix Pharmaceuticals: Plans to Develop Tnx-3900 Series of Molecules As Oral Antivirals Either As Monotherapy Or in Combination With Other Antivirals.